Retrospective Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Oct 21, 2020; 26(39): 6037-6046
Published online Oct 21, 2020. doi: 10.3748/wjg.v26.i39.6037
Figure 1
Figure 1 Metastatic sites of patients with esophageal cancer. Other metastases of esophageal cancer (all types) with proportion ≥ 2%: pancreas (6%), brain (4%), mediastinum (3%), skin/subcutis (3%), thyroid gland (3%), spleen (3%), gallbladder (2%). AC: Adenocarcinoma; SSC: Squamous cell carcinoma.
Figure 2
Figure 2 Metastatic pattern of esophageal and gastric cancer by histological subtype. AC: Adenocarcinoma; SSC: Squamous cell carcinoma.
Figure 3
Figure 3 Metastatic sites of patients with gastric cancer. Other metastases of gastric cancer (all types) with proportion ≥ 2%: heart (7%), kidney (6%), pancreas (5%), thyroid gland (4%), brain (3%), large intestine (3%), small intestine (2%), mediastinum (2%), skin/subcutis (2%), urine bladder (2%). AC: Adenocarcinoma.